These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 24299027)

  • 1. Crohn's disease: is there a place for neurological screening?
    Stovicek J; Liskova P; Lisy J; Hlava S; Keil R
    Scand J Gastroenterol; 2014 Feb; 49(2):173-6. PubMed ID: 24299027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurological adverse events under anti-TNF alpha therapy].
    Cohen M; Baldin B; Thomas P; Lebrun C
    Rev Neurol (Paris); 2012 Jan; 168(1):33-9. PubMed ID: 22098827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory demyelinating events following treatment with anti-tumor necrosis factor.
    Fromont A; De Seze J; Fleury MC; Maillefert JF; Moreau T
    Cytokine; 2009 Feb; 45(2):55-7. PubMed ID: 19109035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: an Australian and New Zealand experience.
    Lawrance IC; Radford-Smith GL; Bampton PA; Andrews JM; Tan PK; Croft A; Gearry RB; Florin TH
    J Gastroenterol Hepatol; 2010 Nov; 25(11):1732-8. PubMed ID: 21039834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral white matter lesions in patients with Crohn's disease.
    Chen M; Lee G; Kwong LN; Lamont S; Chaves C
    J Neuroimaging; 2012 Jan; 22(1):38-41. PubMed ID: 21091817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic inflammatory demyelinating polyradiculoneuropathy associated with central nervous system involvement--as compared to multiple sclerosis].
    Komori T; Ohtake T; Miyazaki Y; Hirose K; Tanabe H
    Rinsho Shinkeigaku; 1990 Sep; 30(9):939-43. PubMed ID: 2265502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk for demyelinating diseases in patients with inflammatory bowel disease.
    Gupta G; Gelfand JM; Lewis JD
    Gastroenterology; 2005 Sep; 129(3):819-26. PubMed ID: 16143121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center.
    Kilic AK; Kurne AT; Oguz KK; Soylemezoglu F; Karabudak R
    Turk Neurosurg; 2013; 23(6):728-35. PubMed ID: 24310455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey.
    Seror R; Richez C; Sordet C; Rist S; Gossec L; Direz G; Houvenagel E; Berthelot JM; Pagnoux C; Dernis E; Melac-Ducamp S; Bouvard B; Asquier C; Martin A; Puechal X; Mariette X;
    Rheumatology (Oxford); 2013 May; 52(5):868-74. PubMed ID: 23287362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study.
    Verhey LH; Branson HM; Shroff MM; Callen DJ; Sled JG; Narayanan S; Sadovnick AD; Bar-Or A; Arnold DL; Marrie RA; Banwell B;
    Lancet Neurol; 2011 Dec; 10(12):1065-73. PubMed ID: 22067635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
    Mühlau M; Buck D; Förschler A; Boucard CC; Arsic M; Schmidt P; Gaser C; Berthele A; Hoshi M; Jochim A; Kronsbein H; Zimmer C; Hemmer B; Ilg R
    Mult Scler; 2013 Oct; 19(11):1485-92. PubMed ID: 23462349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective assessment of the effect on quality of life of anti-tumour necrosis factor therapy for perineal Crohn's fistulas.
    Ng SC; Plamondon S; Gupta A; Burling D; Kamm MA
    Aliment Pharmacol Ther; 2009 Oct; 30(7):757-66. PubMed ID: 19575762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn's perineal fistulas.
    Ng SC; Plamondon S; Gupta A; Burling D; Swatton A; Vaizey CJ; Kamm MA
    Am J Gastroenterol; 2009 Dec; 104(12):2973-86. PubMed ID: 19755971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multiple sclerosis as an adverse effect of anti-tumor necrosis factor agents: an infrequent but important complication of infliximab in Crohn's disease].
    Mir Subías A; García-López S; Sebastián Torres B; Ollero Domenche L; García Gámez A; Gomollón F
    Gastroenterol Hepatol; 2013 Feb; 36(2):81-5. PubMed ID: 23218770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic evaluation of chronic inflammatory intestinal diseases in children and adolescents: MRI with true-FISP as new gold standard?].
    Hohl C; Haage P; Krombach GA; Schmidt T; Ahaus M; Günther RW; Staatz G
    Rofo; 2005 Jun; 177(6):856-63. PubMed ID: 15902636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral venous thrombosis in inflammatory bowel diseases: eight cases and literature review.
    Cognat E; Crassard I; Denier C; Vahedi K; Bousser MG
    Int J Stroke; 2011 Dec; 6(6):487-92. PubMed ID: 22017824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.
    Lebrun C; Bensa C; Debouverie M; Wiertlevski S; Brassat D; de Seze J; Rumbach L; Pelletier J; Labauge P; Brochet B; Tourbah A; Clavelou P;
    Arch Neurol; 2009 Jul; 66(7):841-6. PubMed ID: 19597085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of anti-TNF alpha antibodies in treatment of fistulizing Crohn's disease].
    Rozpondek P; Zwolińska-Wcisło M; Przybylska M; Mach T
    Przegl Lek; 2011; 68(9):602-5. PubMed ID: 22335009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.